Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Hyperpolarized 13C-MRI is an emerging tool for probing tissue metabolism by measuring 13C-label exchange between intravenously injected hyperpolarized [1-13C]pyruvate and endogenous tissue lactate. Here, we demonstrate that hyperpolarized 13C-MRI can be used to detect early response to neoadjuvant therapy in breast cancer. Seven patients underwent multiparametric 1H-MRI and hyperpolarized 13C-MRI before and 7-11 days after commencing treatment. An increase in the lactate-to-pyruvate ratio of approximately 20% identified three patients who, following 5-6 cycles of treatment, showed pathological complete response. This ratio correlated with gene expression of the pyruvate transporter MCT1 and lactate dehydrogenase A (LDHA), the enzyme catalyzing label exchange between pyruvate and lactate. Analysis of approximately 2,000 breast tumors showed that overexpression of LDHA and the hypoxia marker CAIX was associated with reduced relapse-free and overall survival. Hyperpolarized 13C-MRI represents a promising method for monitoring very early treatment response in breast cancer and has demonstrated prognostic potential. SIGNIFICANCE: Hyperpolarized carbon-13 MRI allows response assessment in patients with breast cancer after 7-11 days of neoadjuvant chemotherapy and outperformed state-of-the-art and research quantitative proton MRI techniques.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1538-7445
Volume Title
Publisher
Publisher DOI
Rights
Sponsorship
Wellcome Trust (095962/Z/11/Z)
Cancer Research Uk (None)
Cancer Research UK (C12912/A27150)
Cambridge University Hospitals NHS Foundation Trust (CUH) (3819-1819-07)
Cancer Research UK (C19212/A29082)
Cancer Research UK (CB4100)
Cancer Research UK (C14303/A17197)
Cancer Research UK (unknown)
Cancer Research UK (C96/A25177)
Cancer Research UK (A27657)
Cancer Research UK (unknown)
Cancer Research UK (unknown)
Cancer Research UK (unknown)
Cancer Research UK (60098573)
Cancer Research UK (unknown)
Cancer Research UK (CB4140)
Cancer Research UK (3086)
Cancer Research UK (9401)
Cancer Research UK (16942)
Cancer Research UK (7325)
Cancer Research UK (unknown)
Cancer Research UK (unknown)
Cancer Research UK (unknown)
Cambridge University Hospitals NHS Foundation Trust (CUH) (RG51913)
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Department of Health (via National Institute for Health Research (NIHR)) (unknown)
Medical Research Council (MR/M009041/1)
Department of Health (via National Institute for Health Research (NIHR)) (NF-SI-0515-10090)
Cambridge University Hospitals NHS Foundation Trust (CUH) (Unknown)
Cancer Research UK (7199)
Cancer Research UK (15580)
Cancer Research UK (C507/A16278)
Engineering and Physical Sciences Research Council (NS/A000023/1)
National Institute for Health and Care Research (IS-BRC-1215-20014)
Cancer Research Uk (None)
EPSRC (EP/T017961/1)